SMO ClinPlus CO.,LTD. provides site management services in research and development in pharmaceuticals, medical devices, and health-related products in China. I...
Prologis bonds plummet this week, perpetual notes fall to distressed bond price levels | Lianhe Zaobao
ClinPlus released its performance for the first three quarters, with a net profit attributable to the parent company of 87.3815 million yuan, an increase of 20.92%
Zhitong A-share lock-up release overview | October 28
ClinPlus shareholders view Zhao Tai intends to reduce its holdings by no more than 3%
Innovative drug concept experiences a surge, JOINN hits the daily limit up
ClinPlus released its performance for the first half of the year, with a net profit attributable to the parent company of 54.1561 million yuan, a decrease of 1.40%